9-Me-BC (9-Methyl-beta-carboline): general
9-Me-BC is short for “9-Methyl-beta-carboline”, which PubChem also lists as “9-Methylnorharman”.[1] β-carbolines are a family of compounds the body makes in small amounts, and they “occur inter alia in cooked meat and tobacco smoke”.[2] 9-Me-BC itself is a laboratory compound, sold online as a nootropic. This page is a summary of what is known and what is not. It is not medical advice and it gives no amounts.
What the research found
A German research group reported in 2008: “We identified for the first time a BC (9-methyl-BC; 9-me-BC) exerting neuroprotective and neuron-differentiating effects”, in cultures of dopamine-making nerve cells.[2] Later work in cells and rodents led the same group to write that “The presented results warrant the exploration of 9-me-BC as a novel potential anti-parkinsonian medication”.[3] In rats, a course of treatment “improves spatial learning in the radial maze” and “elevates dopamine levels in the hippocampal formation”.[4] That rat study is the source of the nootropic interest.
All of this is cell and animal work. We found no study that has given 9-Me-BC to people: a PubMed search on 2026-11-21 under its names returned 15 records, all of them cell culture, animal or chemistry papers.[5] That is what our search found. It means there is no human information on what it does at any amount, how long it lasts, what it does over weeks of use, or what side effects people get. There is no established safe amount.
The family it comes from has a mixed record. The rat study notes that β-carbolines “and some of their metabolites can exert neurotoxic effects”, which is why the protective result for 9-Me-BC was a surprise to its authors.[4] One protective compound in a family that includes harmful ones is a reason for caution, not reassurance.
Combining it with other drugs: the MAO question
In laboratory tests, “9-Me-BC showed inhibitory properties to monoamine oxidase (MAO) activity with an IC50 value of 1 µM for MAO-A and of 15.5 µM for MAO-B”.[6] Monoamine oxidase is the enzyme that breaks down serotonin, dopamine and noradrenaline.
Whether 9-Me-BC blocks MAO strongly enough in a person to matter has not been measured.[5] What is known is the risk for the class. A 2022 review of serotonin toxicity states that “True ST typically occurs with a serotonergic drug overdose or in combinations in which a drug that can increase intrasynaptic serotonin is combined with a monoamine oxidase inhibitor (MAOI)”.[7] The review counts common antidepressants among them: “serotonergic drugs like selective serotonin reuptake inhibitors (SSRIs)”.[7] Until someone studies it, combining 9-Me-BC with a serotonergic drug carries a risk that cannot be put to a number. The same review lists the warning signs that need emergency care: “Signs and symptoms warranting immediate medical attention include myoclonus, extreme and fluctuating vital signs, agitation or comatose mental state, muscle rigidity, pronounced hyperthermia (fever), and/or seizure activity”.[7]
Light sensitivity
One worry about 9-Me-BC is sensitivity to sunlight. The chemistry behind it is real, but it comes from test-tube work. A 2013 study notes that “It has been well documented that β-carboline alkaloids, particularly the 9-methyl derivatives, are efficient photosensitizers”, and tested “9-methyl-norharmane”, another name for 9-Me-BC, among others.[8][1] Those compounds were able “to induce DNA damage upon UVA excitation at physiological pH”, meaning that under ultraviolet light they damaged DNA in solution.[8] Nobody has tested whether that happens in the skin or eyes of someone taking it. It is an open question, and the experiences section collects what readers report.
What is not known
How it is absorbed and broken down in people, whether it reaches the brain, its effects on blood pressure and heart rate, and how it interacts with medicines are all unknown.[5] The legal section covers its status.
References
- 9-Methyl-beta-carboline, PubChem compound record CID 164979 (synonyms list) — National Center for Biotechnology Information, PubChem
- 9-Methyl-beta-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic culture (Hamann et al., Neurochemistry International, 2008) — PubMed (US National Library of Medicine)
- The exceptional properties of 9-methyl-beta-carboline: stimulation, protection and regeneration of dopaminergic neurons coupled with anti-inflammatory effects (Polanski et al., Journal of Neurochemistry, 2010) — PubMed (US National Library of Medicine)
- 9-Methyl-β-carboline-induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferation (Gruss et al., Journal of Neurochemistry, 2012) — PubMed (US National Library of Medicine)
- PubMed search for 9-methyl-beta-carboline, 9-Me-BC and 9-methylnorharmane (run 2026-11-21: 15 records, cell culture, animal and chemistry studies; none in people) — PubMed (US National Library of Medicine)
- 9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes (Keller et al., Journal of Neural Transmission, 2020) — PubMed (US National Library of Medicine)
- Serotonin toxicity of serotonergic psychedelics (Malcolm and Thomas, Psychopharmacology, 2022) — PubMed (US National Library of Medicine)
- Mechanisms of DNA damage by photoexcited 9-methyl-β-carbolines (Vignoni et al., Organic & Biomolecular Chemistry, 2013) — PubMed (US National Library of Medicine)
Comments
Sign in to join the conversation.
No comments yet.